litlas
ログインアカウント作成

Alberto Sobrero

1992–2025 年に発表

77
論文数
24,821
被引用数
56
h 指数
74
i10 指数

被引用数

Alberto Sobrero の年別被引用数1991 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 4 件1995 年: 被引用 5 件1996 年: 被引用 2 件1997 年: 被引用 3 件1998 年: 被引用 12 件1999 年: 被引用 9 件2000 年: 被引用 11 件2001 年: 被引用 10 件2002 年: 被引用 25 件2003 年: 被引用 26 件2004 年: 被引用 20 件2005 年: 被引用 34 件2006 年: 被引用 31 件2007 年: 被引用 34 件2008 年: 被引用 57 件2009 年: 被引用 78 件2010 年: 被引用 110 件2011 年: 被引用 90 件2012 年: 被引用 99 件2013 年: 被引用 118 件2014 年: 被引用 183 件2015 年: 被引用 151 件2016 年: 被引用 166 件2017 年: 被引用 231 件2018 年: 被引用 189 件2019 年: 被引用 840 件2020 年: 被引用 869 件2021 年: 被引用 861 件2022 年: 被引用 613 件2023 年: 被引用 455 件2024 年: 被引用 768 件2025 年: 被引用 325 件2026 年: 被引用 14 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,470 件、この内訳の 16.5%中国: 引用元論文 915 件、この内訳の 10.3%イタリア: 引用元論文 801 件、この内訳の 9%イギリス: 引用元論文 528 件、この内訳の 6%フランス: 引用元論文 501 件、この内訳の 5.6%ドイツ: 引用元論文 447 件、この内訳の 5%日本: 引用元論文 438 件、この内訳の 4.9%スペイン: 引用元論文 426 件、この内訳の 4.8%ベルギー: 引用元論文 292 件、この内訳の 3.3%オランダ: 引用元論文 286 件、この内訳の 3.2%カナダ: 引用元論文 242 件、この内訳の 2.7%オーストラリア: 引用元論文 216 件、この内訳の 2.4%
0%16.5%その他 26.3%

機関

分野

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology16%
  • Immunology and Microbiology1.4%
  • Economics, Econometrics and Finance1.2%
  • Computer Science0.6%
  • Materials Science0.6%
  • その他2.8%

トピック

  • Colorectal Cancer Treatments and Studies15.1%
  • Colorectal Cancer Surgical Treatments5.7%
  • Hepatocellular Carcinoma Treatment and Prognosis5.1%
  • Genetic factors in colorectal cancer5%
  • Cancer Immunotherapy and Biomarkers4%
  • Cancer Genomics and Diagnostics3.8%
  • その他61.3%

共著者

全論文

検索で開く
  1. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    著者: Axel Grothey, Eric Van Cutsem, Alberto Sobrero, Salvatore Siena, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Josep Tabernero, Takayuki Yoshino, Heinz‐Josef Lenz, Richard M. Goldberg, Daniel J. Sargent, Frank Cihon, Lisa Cupit, Andrea Wagner, Dirk Laurent - The Lancet 2012 被引用: 2,897

  2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    著者: Eric Van Cutsem, Andrés Cervantes, René Adam, Alberto Sobrero, J. Han van Krieken, Dan Aderka, E. Aranda Aguilar, Alberto Bardelli, Al B. Benson, G. Bodoky, Fortunato Ciardiello, André D’Hoore, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Michel Ducreux, Alfredo Falcone, Axel Grothey, Thomas Gruenberger, Karin Haustermans, Volker Heinemann, Paulo M. Hoff, C.-H. Köhne, Roberto Labianca, Pierre Laurent‐Puig, Brigette Ma, Tim Maughan, Kei Muro, Nicola Normanno, Pia Österlund, Wim J.G. Oyen, Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 被引用: 3,449

  3. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    著者: Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio García‐Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu, Alberto Sobrero, Éveline Boucher, Marc Peeters, Ben Tran, Heinz‐Josef Lenz, Alberto Zaniboni, Howard S. Höchster, James M. Cleary, Hans Prenen, Fabio Benedetti, Hirokazu Mizuguchi, Lukas Makris, Masanobu Ito, Atsushi Ohtsu - New England Journal of Medicine 2015 被引用: 1,431

  4. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

    著者: Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero, Elena Élez, Takayuki Yoshino, Alberto Sobrero, James C. Yao, Pilar García‐Alfonso, Judit Kocsis, Antonio Cubillo Gracián, Andrea Sartore‐Bianchi, Taroh Satoh, Violaine Randrian, Jiří Tomášek, Geoff Chong, Andrew Scott Paulson, Toshiki Masuishi, Jeremy Jones, Tibor Csőszi, Chiara Cremolini, François Ghiringhelli, Ardaman Shergill, Howard S. Höchster, John C. Krauss, Ali Bassam, Michel Ducreux, Anneli Elme, Laurence Faugeras, Stefan Kasper, Eric Van Cutsem, Dirk Arnold, Shivani Nanda, Zhao Yang, William R. Schelman, Marek Kania, Josep Tabernero, Cathy Eng - The Lancet 2023 被引用: 323

  5. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    著者: Axel Grothey, Alberto Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taı̈eb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca, Jeffrey A. Meyerhardt, Déwi Vernerey, Takeharu Yamanaka, Ioannis Boukovinas, Jeffrey P. Meyers, Lindsay A. Renfro, Donna Niedzwiecki, Toshiaki Watanabe, Valter Torri, Mark Saunders, Daniel J. Sargent, Thierry André, Timothy Iveson - New England Journal of Medicine 2018 被引用: 1,126

  6. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

    著者: Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argilés, Niall C. Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark Kozloff, Neil H. Segal, Alberto Sobrero, Yibing Yan, Ilsung Chang, Anne Uyei, Louise Roberts, Fortunato Ciardiello, JB Ahn, Jamil Asselah, Suprith Badarinath, Shobhit Baijal, S. Begbie, Sneha Berry, J. R. Canon, RG Carbone, Andrés Cervantes, YJ Cha, Karen Chang, Arvind Chaudhry, Ewa Chmielowska, Seung‐Hun Cho, Derek K. Chu, Félix Couture, Jennifer L. Cultrera, David Cunningham, Eric Van Cutsem, P-J. Cuyle, Janine M. Davies, Scot Dowden, Mikhail Dvorkin, Vinod Ganju, RV Garcia, Rachel Kerr, Tae‐Yop Kim, Kevin G. King, Jeremy Kortmansky, Mark Kozloff, Ko Lam, J Lee, AS Lee, Bernard Lespérance, Gabriele Luppi, Boyu Ma, Evaristo Maiello, Romeo A. Mandanas, J. L. Marshall, Gavin Marx, Saifee Mullamitha, Marina Nechaeva, Jo Park, Nick Pavlakis, CG Ponce, Piotr Potemski, Sherif Raouf, James A. Reeves, Neil H. Segal, Salvatore Siena, Alexey Smolin, JO Streb, A. H. Strickland, Ewa Szutowicz-Zielińska, Josep Tabernero, Benjamin Tan, JS Valera, Marc Van den Eynde, Philippe Vergauwe, Michael M. Vickers, Mark Womack, Marta Wróblewska, Ruth T. Young - The Lancet Oncology 2019 被引用: 562

  7. Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    著者: Daniel J. Sargent, Alberto Sobrero, Axel Grothey, Michael J. O’Connell, Marc Buyse, Thierry André, Yan Zheng, Erin Green, Roberto Labianca, Chris J. O’Callaghan, Jean François Seitz, Guido Francini, Daniel G. Haller, Greg Yothers, Richard M. Goldberg, Aimery de Gramont - Journal of Clinical Oncology 2009 被引用: 676

  8. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

    著者: J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin, Hyun Cheol Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Yaroslav Shparyk, Paulo M. Hoff, Alberto Sobrero, Pamela Salman, Jin Li, Светлана Проценко, Zev A. Wainberg, Marc Buyse, Karen Afenjar, Vincent Houé, Agathe Garcia, Tomomi Kaneko, Yingjie Huang, S. Khan‐Wasti, Sergio Santillana, Michael F. Press, Dennis J. Slamon - Journal of Clinical Oncology 2015 被引用: 621

  9. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

    著者: René Adam, Aimery de Gramont, Joan Figueras, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Catherine Teh, Sabine Tejpar, Eric Van Cutsem, Jean‐Nicolas Vauthey, Lars Påhlman - Cancer Treatment Reviews 2015 被引用: 601

  10. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    著者: Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Axel Grothey, Donna Niedzwiecki, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Déwi Vernerey, Jeffrey P. Meyers, Andrea Harkin, Valter Torri, Eiji Oki, Vassilis Georgoulias, Julien Taı̈eb, Anthony F. Shields, Qian Shi - The Lancet Oncology 2020 被引用: 298

  11. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    著者: Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Vincenzo Valentini, Bengt Glimelius, Karin Haustermans, Bernard Nordlinger, Cornelis JH van de Velde, Judith Balmañà, Jarosław Reguła, Irıs D. Nagtegaal, Geerard L. Beets, Dirk Arnold, Fortunato Ciardiello, Paulo M. Hoff, David J. Kerr, C.-H. Köhne, Roberto Labianca, Timothy Price, Werner Scheithauer, Alberto Sobrero, Josep Tabernero, Dan Aderka, Sérgio Barroso, G. Bodoky, Jean‐Yves Douillard, Hesham El Ghazaly, J. Gallardo, A. Garin, Rob Glynne‐Jones, Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 被引用: 1,534

  12. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

    著者: Nathan I. Cherny, Richard Sullivan, Urania Dafni, J. Martijn Kerst, Alberto Sobrero, Christoph Zielinski, Elisabeth G.E. de Vries, Martine Piccart - Annals of Oncology 2015 被引用: 807

  13. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

    著者: Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, Sara Lonardi, Fotios Loupakis, Filippo Pietrantonio, Roberto Bordonaro, Tiziana Pia Latiano, Emiliano Tamburini, Daniele Santini, Alessandro Passardi, Federica Marmorino, Roberta Grande, Giuseppe Aprile, Alberto Zaniboni, Sabina Murgioni, Cristina Granetto, Angela Buonadonna, Roberto Moretto, Salvatore Corallo, Stefano Cordio, Lorenzo Antonuzzo, Gianluca Tomasello, Gianluca Masi, Monica Ronzoni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Giuliana Ritorto, Andrea Mambrini, Mario Roselli, Samanta Cupini, Serafina Mammoliti, Elisabetta Fenocchio, E. Corgna, Vittorina Zagonel, Gabriella Fontanini, Clara Ugolini, Luca Boni, Alfredo Falcone, Alfredo Falcone, Sara Lonardi, Filippo de Braud, Roberto Bordonaro, Evaristo Maiello, Emiliano Tamburini, Daniele Santini, Giovanni Luca Frassineti, Teresa Gamucci, Giuseppe Aprile, Alberto Zaniboni, Cristina Granetto, Angela Buonadonna, Francesco Di Costanzo, Gianluca Tomasello, Luca Gianni, Samantha Di Donato, Chiara Carlomagno, Matteo Clavarezza, Patrizia Racca, Andrea Mambrini, Mario Roselli, Giacomo Allegrini, Alberto Sobrero, Massimo Aglietta, E. Corgna, Enrico Cortesi, Domenico Corsi, Alberto Ballestrero, Andrea Bonetti, Francesco Clemente, Enzo Maria Ruggeri, Fortunato Ciardiello, Marco Benasso, S. Vitello, Saverio Cinieri, Stefania Mosconi, Nicola Silvestris, Antonio Frassoldati, S. Cupini, Alessandro Bertolini, Giampaolo Tortora, Carmelo Bengala, Daris Ferrari, Antonia Ardizzoia, Carlo Milandri, Silvana Chiara, Gianpiero Romano, Stefania Miraglia, Laura Scaltriti, Francesca Pucci, Livio Blasi, Silvia Brugnatelli, Luisa Fioretto, Angela Stefania Ribecco, Raffaella Longarini, M. Frisinghelli, Maria Banzi - The Lancet Oncology 2020 被引用: 325

  14. The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus

    著者: René Adam, Aimery de Gramont, Joan Figueras, Ashley Guthrie, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Josep Tabernero, Catherine Teh, Eric Van Cutsem, Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group - The Oncologist 2012 被引用: 594

  15. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin

    著者: Elisa Fontana, Jeff Meyers, Alberto Sobrero, Timothy Iveson, Anthony F. Shields, Julien Taieb, Takayuki Yoshino, Ioannis Souglakos, Elizabeth C. Smyth, Florian Lordick, Markus Moehler, Anne Giraut, Andrea Harkin, Roberto Labianca, Jeffrey Meyerhardt, Thierry André, Ioannis Boukovinas, Sara Lonardi, Mark Saunders, Dewi Vernerey, Eiji Oki, Vassilis Georgoulias, Irit Ben-Aharon, Qian Shi - Journal of Clinical Oncology 2021 被引用: 104

  16. Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials

    著者: Cornelis J. A. Punt, Marc Buyse, C.-H. Köhne, Peter Hohenberger, Roberto Labianca, Hans‐Joachim Schmoll, Lars Påhlman, Alberto Sobrero, Jean‐Yves Douillard - JNCI Journal of the National Cancer Institute 2007 被引用: 378

  17. Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

    著者: Timothy Iveson, Alberto Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang‐Shu Ou, Jeffrey P. Meyers, Qian Shi, Axel Grothey, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul - Journal of Clinical Oncology 2021 被引用: 104

  18. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

    著者: Marc Peeters, Timothy Price, Andrés Cervantes, Alberto Sobrero, Michel Ducreux, Yevhen Hotko, Thierry André, Emily Chan, Florian Lordick, Cornelis J.A. Punt, Andrew Strickland, G. Wilson, Tudor–Eliade Ciuleanu, Laslo Roman, Eric Van Cutsem, Valentina Tzekova, Simon Collins, Kelly S. Oliner, Alan Rong, Jennifer Gansert - Journal of Clinical Oncology 2010 被引用: 1,001

  19. Prognostic and predictive molecular biomarkers in advanced colorectal cancer

    著者: Valentino Martelli, Alessandro Pastorino, Alberto Sobrero - Pharmacology & Therapeutics 2022 被引用: 70

  20. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

    著者: Alberto Sobrero, Joan Maurel, Louis Fehrenbacher, Werner Scheithauer, Yousif Abubakr, Manfred P. Lutz, M. E. Vega-Villegas, Cathy Eng, E.U. Steinhauer, Jana Prausová, Heinz‐Josef Lenz, Christophe Borg, Gary Middleton, H. Kröning, Gabriele Luppi, O. Kisker, Angela Zubel, Christiane Langer, Justin Kopit, Howard A. Burris - Journal of Clinical Oncology 2008 被引用: 952

  21. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

    著者: Josep Tabernero, Heinz‐Josef Lenz, Salvatore Siena, Alberto Sobrero, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Takayuki Yoshino, Richard M. Goldberg, Daniel J. Sargent, Andrea Wagner, Dirk Laurent, Michael Teufel, Michael Jeffers, Axel Grothey, Eric Van Cutsem - The Lancet Oncology 2015 被引用: 326

  22. A new prognostic and predictive tool for shared decision making in stage III colon cancer

    著者: Alberto Sobrero, Alberto Puccini, Qian Shi, Axel Grothey, Thierry André, Anthony F. Shields, Ioannis Souglakos, Takayuki Yoshino, Timothy Iveson, Marcello Ceppi, Paolo Bruzzi - European Journal of Cancer 2020 被引用: 69

  23. Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

    著者: Eric Van Cutsem, Roberto Labianca, G. Bodoky, C. Barone, Enrique Aranda, Bernard Nordlinger, Claire Topham, Josep Tabernero, Thierry André, Alberto Sobrero, Enrico Mini, Richard Greil, Francesco Di Costanzo, Laurence Collette, Laura A. Cisar, Xiaoxi Zhang, David Khayat, Carsten Bokemeyer, Arnaud Roth, David Cunningham - Journal of Clinical Oncology 2009 被引用: 468

  24. FRESCO-2: A Global Phase III Study Investigating the Efficacy and Safety of Fruquintinib in Metastatic Colorectal Cancer

    著者: Arvind Dasari, Alberto Sobrero, James C. Yao, Takayuki Yoshino, William R. Schelman, Zhao Yang, Caly Chien, Marek Kania, Josep Tabernero, Cathy Eng - Future Oncology 2021 被引用: 51